Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03352791 · ClinicalTrials.gov registry record · NA

The Dementia Symptom Management at Home Program Hospice Edition

A NA study, sponsored by NYU Langone Health.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT03352791 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03352791, a NA study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare and hospice, most clinicians and agencies are ill prepared to care for this population and therefore have difficulty assisting patients and caregivers in maintaining quality of life leading to adverse patient outcomes, increased caregiver stress and burnout, and healthcare utilization. This study will utilize a cluster randomized controlled design with 6 care teams at a single study site to examine the ability of a multi-component evidence-based practice hospice care quality improvement program for registered nurses, social workers and chaplains to improve the quality of life and reduce healthcare utilization for persons with dementia and their informal caregiver.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL DSM-H Hospice Edition performance improvement program

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2018-08-01
Est. Completion 2018-10-05
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03352791

The ClinicalTrials.gov registry entry for NCT03352791 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT03352791 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03352791 about?

NCT03352791 is a clinical study titled "The Dementia Symptom Management at Home Program Hospice Edition". Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare and hospice, most clinicians and agencies are ill prepared to care for...

What is the current status of trial NCT03352791?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-08-01. Estimated completion is 2018-10-05.

What interventions are being tested in trial NCT03352791?

The interventions under investigation include: Usual Care (BEHAVIORAL), DSM-H Hospice Edition performance improvement program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03352791?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.